Saatja: NRA WHO Europe <
[email protected]>
Saadetud: 26.03.2021 00:51
Adressaat: Elen Ohov <
[email protected]>
Koopia: Triin Uusberg <
[email protected]>; SM Info <
[email protected]>;
<
[email protected]>; <
[email protected]>; <
[email protected]>;
<
[email protected]>; KÖHLER, Kristina <
[email protected]>;
LINDHARDT, Lisbeth Sjaelborg <
[email protected]>; LITTLEWOOD, Jodie Anne
<
[email protected]>
Teema: EST_Nomination letter_‘WHO/Europe medicines and health products
regulatory support’
Tähtsus: Kõrgeim
Please see the attached correspondence sent from the World Health
Organization, Regional Office for Europe. One or more attachments may be
included.
Ñì. ïðèêðåïëåííûå ïèñüìà îò Åâðîïåéñêîãî ðåãèîíàëüíîãî áþðî Âñåìèðíîé
îðãàíèçàöèè çäðàâîîõðàíåíèÿ (îäèí èëè íåñêîëüêî ïðèêðåïëåííûõ ôàéëîâ).
WORLD HEALTH ORGANIZATION
ORGANISATION MONDIALE DE LA SANTÉ
WELTGESUNDHEITSORGANISATION
ВСЕМИРНАЯ ОРГАНИЗАЦИЯ ЗДРАВООХРАНЕНИЯ
Date: 25 March 2021
REGIONAL OFFICE FOR EUROPE Ms Elen Ohov
BUREAU RÉGIONAL DE L’EUROPE
REGIONALBÜRO FÜR EUROPA
Adviser
ЕВРОПЕЙСКОЕ РЕГИОНАЛЬНОЕ БЮРО European Union Affairs and International Co-
Head office:
operation Department
UN City, Marmorvej 51, Ministry of Social Affairs
DK-2100 Copenhagen Ø, Denmark Suur-Ameerika 1
Tel.: +45 45 33 70 00; Fax: +45 45 33 70 01
Website: http://www.euro.who.int 10122 Tallinn
Estonia
Our reference: Your reference:
Notre référence: Votre référence:
Unser Zeichen: Ihr Zeichen:
См. наш номер: На Ваш номер:
Dear Ms Ohov,
WHO/Europe medicines and health products regulatory support
In response to the unprecedented challenges relating to the provision of equitable access to COVID19
medicines including vaccines, WHO/Europe is providing enhanced support to national regulatory
authorities (NRAs) and governments for regulatory preparedness for medicines and health products
(MHP).
MHP markets differ from other retail markets as they require extensive regulation to ensure the MHP in
circulation meet the standards for quality, safety, and effectiveness. A strong MHP regulatory system
builds public confidence in health care systems and professionals and protects the public from exposure to
substandard and falsified (SF) MHP.
WHO/Europe supports NRAs and governments through a regulatory support group to contribute to the
strengthening and development of the regulatory system for MHP. This includes promoting the
participation of NRAs in existing international and regional regulatory initiatives including benchmarking;
prioritizing support for establishing and strengthening regional and sub regional NRAs networks; and
facilitating the strengthening of NRAs, which includes capacity building.
As part of its work, this group will meet virtually to enable rapid communication and provide support for
legal and regulatory aspects associated with access to medicines, including COVID19 vaccines. Support
will also include the provision of information updates and guidance on relevant procedures and raising
awareness of the critical need to involve NRAs in deployment and safety monitoring.
WHO/Europe kindly requests that you nominate a National Focal Point and a deputy, by providing the
names and email addresses to
[email protected], by 15 April 2021 at the latest to join the
informal regulatory support group on MHP.
Should you have any questions or require any further information, please do not hesitate to contact us by
email, at the address above.
Sincerely yours,
Dr Natasha Azzopardi Muscat
Director
Division of Country Health Policies and Systems
UN City, Marmorvej 51 Tel.: +45 45 33 70 00 Email:
[email protected]
DK-2100 Copenhagen Ø Fax: +45 45 33 70 01 Website: http://www.euro.who.int
Denmark
Copy for information to:
Ms Triin Uusberg, Head, European and International Coordination Department, Ministry of Social Affairs,
Suur-Ameerika 1, 10129 Tallinn, Estonia
H.E. Ms Katrin Saarsalu-Layachi, Ambassador Extraordinary and Plenipotentiary, Permanent Representative,
Permanent Mission of the Republic of Estonia to the United Nations Office and other international
organizations in Geneva, Chemin du Petit-Saconnex 28A, CH-1209 Genève, Switzerland
H.E. Mr William Mart Laanemäe, Ambassador Extraordinary and Plenipotentiary, Embassy of the Republic of
Estonia, Frederiksgade 19, 4th floor, 1265 Copenhagen K, Denmark
Ms Kristina Köhler, Liaison Officer, WHO Country Office, Estonia, Paldiski Road 81, 10617 Tallinn, Estonia
–2 –